Literature DB >> 9385104

An analytic method for randomized trials with informative censoring: Part 1.

J M Robins1.   

Abstract

Consider a randomized trial in which time to the occurrence of a particular disease, say pneumocystis pneumonia in an AIDS trial or breast cancer in a mammographic screening trial, is the failure time of primary interest. Suppose that time to disease is subject to informative censoring by the minimum of time to death, loss to and end of follow-up. In such a trial, the censoring time is observed for all study subjects, including failures. In the presence of informative censoring, it is not possible to consistently estimate the effect of treatment on time to disease without imposing additional non-identifiable assumptions. The goals of this paper are to specify two non-identifiable assumptions that allow one to test for and estimate an effect of treatment on time to disease in the presence of informative censoring. In a companion paper (Robins, 1995), we provide consistent and reasonably efficient semiparametric estimators for the treatment effect under these assumptions. In this paper we largely restrict attention to testing. We propose tests that, like standard weighted-log-rank tests, are asymptotically distribution-free alpha-level tests under the null hypothesis of no causal effect of treatment on time to disease whenever the censoring and failure distributions are conditionally independent given treatment arm. However, our tests remain asymptotically distribution-free alpha-level tests in the presence of informative censoring provided either of our assumptions are true. In contrast, a weighted log-rank test will be an alpha-level test in the presence of informative censoring only if (1) one of our two non-identifiable assumptions hold, and (2) the distribution of time to censoring is the same in the two treatment arms. We also extend our methods to studies of the effect of a treatment on the evolution over time of the mean of a repeated measures outcome, such as CD-4 count.

Entities:  

Mesh:

Year:  1995        PMID: 9385104     DOI: 10.1007/bf00985759

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  3 in total

1.  Bounds for a joint distribution function with fixed sub-distribution functions: Application to competing risks.

Authors:  A V Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

2.  An analytic method for randomized trials with informative censoring: Part II.

Authors:  J M Robins
Journal:  Lifetime Data Anal       Date:  1995       Impact factor: 1.588

3.  A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods.

Authors:  J Robins
Journal:  J Chronic Dis       Date:  1987
  3 in total
  14 in total

1.  Evaluating candidate principal surrogate endpoints.

Authors:  Peter B Gilbert; Michael G Hudgens
Journal:  Biometrics       Date:  2008-03-24       Impact factor: 2.571

2.  Semiparametric estimation of treatment effects given base-line covariates on an outcome measured after a post-randomization event occurs.

Authors:  Yannis Jemiai; Andrea Rotnitzky; Bryan E Shepherd; Peter B Gilbert
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2007-11-01       Impact factor: 4.488

3.  An analytic method for randomized trials with informative censoring: Part II.

Authors:  J M Robins
Journal:  Lifetime Data Anal       Date:  1995       Impact factor: 1.588

4.  Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity Analysis.

Authors:  Bryan E Shepherd; Mary W Redman; Donna P Ankerst
Journal:  J Am Stat Assoc       Date:  2008-12-01       Impact factor: 5.033

5.  Randomization-Based Inference within Principal Strata.

Authors:  Tracy L Nolen; Michael G Hudgens
Journal:  J Am Stat Assoc       Date:  2011-06       Impact factor: 5.033

6.  Semicompeting risks in aging research: methods, issues and needs.

Authors:  Ravi Varadhan; Qian-Li Xue; Karen Bandeen-Roche
Journal:  Lifetime Data Anal       Date:  2014-04-12       Impact factor: 1.588

7.  Evaluating a surrogate endpoint at three levels, with application to vaccine development.

Authors:  Peter B Gilbert; Li Qin; Steven G Self
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

8.  Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected Postrandomization.

Authors:  Bryan E Shepherd; Peter B Gilbert; Thomas Lumley
Journal:  J Am Stat Assoc       Date:  2007-06       Impact factor: 5.033

9.  On assessing surrogacy in a single trial setting using a semicompeting risks paradigm.

Authors:  Debashis Ghosh
Journal:  Biometrics       Date:  2009-06       Impact factor: 2.571

10.  Covariate adjustment using propensity scores for dependent censoring problems in the accelerated failure time model.

Authors:  Youngjoo Cho; Chen Hu; Debashis Ghosh
Journal:  Stat Med       Date:  2017-10-10       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.